IN2014DN08385A - - Google Patents

Info

Publication number
IN2014DN08385A
IN2014DN08385A IN8385DEN2014A IN2014DN08385A IN 2014DN08385 A IN2014DN08385 A IN 2014DN08385A IN 8385DEN2014 A IN8385DEN2014 A IN 8385DEN2014A IN 2014DN08385 A IN2014DN08385 A IN 2014DN08385A
Authority
IN
India
Prior art keywords
antithrombin
pre eclampsia
atryn
treatment
disclosure provides
Prior art date
Application number
Other languages
English (en)
Inventor
Johan Frieling
Simon Lowry
Original Assignee
Lfb Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lfb Usa Inc filed Critical Lfb Usa Inc
Publication of IN2014DN08385A publication Critical patent/IN2014DN08385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN8385DEN2014 2012-03-12 2013-03-12 IN2014DN08385A (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261609534P 2012-03-12 2012-03-12
PCT/US2013/030350 WO2013138271A1 (en) 2012-03-12 2013-03-12 The use of antithrombin in the treatment of pre-eclampsia

Publications (1)

Publication Number Publication Date
IN2014DN08385A true IN2014DN08385A (enrdf_load_html_response) 2015-05-08

Family

ID=49161701

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8385DEN2014 IN2014DN08385A (enrdf_load_html_response) 2012-03-12 2013-03-12

Country Status (12)

Country Link
US (1) US20140206617A1 (enrdf_load_html_response)
EP (1) EP2825194A4 (enrdf_load_html_response)
JP (1) JP2015509984A (enrdf_load_html_response)
KR (1) KR20140135219A (enrdf_load_html_response)
CN (1) CN104321076A (enrdf_load_html_response)
AR (1) AR090315A1 (enrdf_load_html_response)
AU (1) AU2013203512B2 (enrdf_load_html_response)
CA (1) CA2871159A1 (enrdf_load_html_response)
IN (1) IN2014DN08385A (enrdf_load_html_response)
MX (1) MX2014010940A (enrdf_load_html_response)
TW (1) TW201400499A (enrdf_load_html_response)
WO (1) WO2013138271A1 (enrdf_load_html_response)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103429272A (zh) 2010-12-30 2013-12-04 法国化学与生物科技实验室 作为病原体灭活剂的二元醇
CA2879763C (en) 2012-08-03 2020-12-01 Simon LOWRY The use of antithrombin in extracorporeal membrane oxygenation
BR112015019341A2 (pt) 2013-02-13 2017-08-22 Lab Francais Du Fractionnement Anticorpo anti-tnf-alfa, composição que compreende o anticorpo, método para produzir uma população de anticorpos, células epiteliais da glândula mamária, mamífero não humano transgênico, e, composição de anticorpo anti-tnf monoclonal
TW201446962A (zh) 2013-02-13 2014-12-16 Lab Francais Du Fractionnement 具有修飾的糖化作用之蛋白質及其製造方法
AU2014285971A1 (en) 2013-07-05 2016-02-04 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Affinity chromatography matrix
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
WO2021073518A1 (zh) * 2019-10-17 2021-04-22 中国科学院动物研究所 纤溶酶抑制因子的抑制剂用于预防或治疗子痫前期或子痫的用途
CN113406326B (zh) * 2021-06-01 2022-08-26 大连医科大学 一种用于预测子痫前期的生物学标志物及其应用
CN118593717A (zh) * 2024-05-31 2024-09-06 厦门特宝生物工程股份有限公司 一种用于治疗和/或预防子痫前期发生的药物组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264166B1 (en) 1986-04-09 1996-08-21 Genzyme Corporation Transgenic animals secreting desired proteins into milk
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
US20050271660A1 (en) * 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
EP1776108A1 (en) * 2004-06-23 2007-04-25 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
CN101137396A (zh) * 2005-03-11 2008-03-05 弗雷泽纽斯卡比德国有限公司 由无活性初始材料制备生物活性糖蛋白
US20070037192A1 (en) * 2005-07-25 2007-02-15 Gtc Biotherapeutics, Inc. Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
US7521632B2 (en) 2006-08-31 2009-04-21 Gaton Corporation Door hinge assembly and enclosure employing the same

Also Published As

Publication number Publication date
US20140206617A1 (en) 2014-07-24
TW201400499A (zh) 2014-01-01
JP2015509984A (ja) 2015-04-02
KR20140135219A (ko) 2014-11-25
AU2013203512A1 (en) 2013-09-26
AR090315A1 (es) 2014-11-05
WO2013138271A1 (en) 2013-09-19
CA2871159A1 (en) 2013-09-19
CN104321076A (zh) 2015-01-28
MX2014010940A (es) 2015-04-13
EP2825194A1 (en) 2015-01-21
AU2013203512B2 (en) 2016-02-25
EP2825194A4 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
IN2014DN08385A (enrdf_load_html_response)
ZA202208792B (en) Methods of treating and preventing graft versus host disease
HK1220980A1 (zh) 用於治療龐貝氏症的方法和組合物
UA118248C2 (uk) Інгібітори глюкозилцерамідсинтази
TW201611843A (en) Methods of treatment with arginine deiminase
IN2015DN01156A (enrdf_load_html_response)
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
MX369691B (es) Inhibidores de glutaminasa y métodos de empleo.
MX2015014431A (es) Monoterapia con glucopiranosil lipido a para usarse en el tratamieto del cancer.
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
PH12014500075A1 (en) Pharmaceutical composition, methods for treating and uses thereof
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
WO2012092336A3 (en) Molecular profiling for cancer
AU2011328009A8 (en) Compounds and methods for treating pain
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
PH12013502487A1 (en) Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
MX349886B (es) Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas.
NZ628433A (en) Chitosan-derived compositions
IN2014CN04634A (enrdf_load_html_response)
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
GB201109238D0 (en) Antibodies
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
EP3449917A3 (en) Tapentadol for preventing chronification of pain